Compare SXTC & OPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SXTC | OPP |
|---|---|---|
| Founded | 2005 | 2010 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 177.7M | 198.2M |
| IPO Year | 2019 | N/A |
| Metric | SXTC | OPP |
|---|---|---|
| Price | $2.52 | $7.96 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 697.1K | 108.0K |
| Earning Date | 08-19-2019 | 01-01-0001 |
| Dividend Yield | N/A | ★ 14.41% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,537,987.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.34 | $7.26 |
| 52 Week High | $1,175.99 | $8.83 |
| Indicator | SXTC | OPP |
|---|---|---|
| Relative Strength Index (RSI) | 59.84 | 60.08 |
| Support Level | $2.34 | $7.90 |
| Resistance Level | $6.40 | $8.00 |
| Average True Range (ATR) | 0.42 | 0.05 |
| MACD | 0.24 | 0.01 |
| Stochastic Oscillator | 39.18 | 78.83 |
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.